Current Trends of Combination Therapy in Chronic Hepatitis B Management in China
Journal Title: Archives of Hepatitis Research - Year 2015, Vol 1, Issue 1
Abstract
In the past decade, five oral nucleos(t)ide analogs and two formulations of pegylated interferon alpha have been approved for the treatment of chronic hepatitis B (CHB). Due to low personal income and inadequate health care system, low-to-moderate genetic barrier antiviral drugs are still widely used in China, which brings increased suboptimal response, viral relapse and resistance in real-life clinical practice. Combination therapy is a relative good approach to deal with these dilemma in Chinese CHB patients, and the strategies include de novo combination, rescue combination therapy, and optimized combination therapy. At present, combination therapy could be sonsidered for those who have suboptimal response to antiviral drugs, at high risk of complications in the event of virological breakthrough/rebound, or already with drug-resistant hepatitis B virus infection.
Authors and Affiliations
Chen En-Qiang
Keywords
Related Articles
- EP ID EP558564
- DOI 10.17352/ahr.000001
- Views 33
- Downloads 0
Accidentally discovered Portal Vein Thrombosis before Splenectomy due to Hypersplenism - The role of Thrombogenic Genes Polymorphisms
Portal vein thrombosis in patients with liver cirrhosis may be due neoplastic growth invading portal vein or due to non-neoplastic causes. The indications for treating PVT in cirrhotic individuals are difficult to be est...
Hepatic histological comparison between Acute Self-limiting Hepatitis A and Hepatitis E
Background: Histological findings of the liver in acute liver injury are basically affected by degree of liver damage. However, the differences in liver histology between acute self-limiting hepatitis A (AH-A) and hepati...
Occupational Hazard (Hepatitis B & C)
Hepatitis B and C are considered as an important health hazard among health care workers (HCWs). These blood borne infections can be transmitted either from HCW to a patient or vice-versa. Both viruses are known to cause...
Hepatitis E: Diagnostic and Therapeutic Challenges
HEV infection may be symptomatic or asymptomatic that has affected about one-third of world population with a case fatality rate of 1-2%, including 20-30% of infected pregnant women [3-5]. Though inherently hepatotropic...
Hepatitis E: New Clinical and Public Health Problem on the Western World? Review
Until recently, the occurrence of Hepatitis E in the western hemisphere did not amount to a clinical concern, due to its benign and usually sub-clinical evolution, as opposed to Asia and Africa, where large epidemies wit...